ABBV vs OKTA · P/E 81, rev $16.99B vs P/E 84, rev $1.57B
AbbVie Inc (ABBV) versus Okta Inc (OKTA) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported OKTA revenue for 2026-07-31 was $1.57B. Net income was $190.0M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
Not investment advice. Open the ABBV and OKTA stock pages for the full models.
Not investment advice.